Pharmacotherapeutic group: avian infectious bursal disease virus (Gumboro disease),
ATCvet code: QI01AD09
The active ingredient of the lyophilisate is a live intermediate plus Infectious Bursal Disease-virus strain V217 which stimulates active immunity against IBD-virus.
The strain causes an average score of bursal lesion of 2.9 (out of 5 according to Ph. Eur.) at 21 days post vaccination.